name,sponsor,target_gene_symbol,primary_indication,delivery_type,dbd_type,effector_type,effector_domains,phase,status,description,source_url
PCSK9_CRISPR_EE,Academic (Nature Med),PCSK9,Hypercholesterolemia,LNP_mRNA,CRISPR_dCas9,combo,"[""DNMT3A"",""DNMT3L"",""KRAB""]",,preclinical,CRISPR-based epigenetic editor for durable PCSK9 silencing in NHP with >1 year durability,https://www.nature.com/articles/s41591-024-03282-4
PCSK9_TALE_EpiRegT,Academic (Nat Biotech),PCSK9,Hypercholesterolemia,LNP_mRNA,TALE,combo,"[""ZIM3_KRAB"",""DNMT3A"",""DNMT3L""]",,preclinical,TALE-based epigenetic regulator for PCSK9 silencing with enhanced durability,https://www.nature.com/articles/s41587-024-02449-3
OTX-2002,Omega Therapeutics,MYC,Hepatocellular carcinoma,LNP_mRNA,CRISPR_dCas9,indirect_repressor,"[""programmable_mRNA""]",1,clinical,Programmable epigenetic medicine targeting MYC for HCC - first-in-human Phase 1,https://omegatherapeutics.com
TUNE-401,Tune Therapeutics,PCSK9,Hypercholesterolemia,LNP_mRNA,ZF,combo,"[""KRAB"",""DNMT3A"",""DNMT3L""]",,preclinical,Zinc finger-based epigenetic editor for cardiovascular disease,https://www.tunetx.com
HBV_EpiSilencer,Chroma Medicine,cccDNA,Hepatitis B,LNP_mRNA,CRISPR_dCas9,combo,"[""KRAB"",""DNMT3A""]",,preclinical,Epigenetic silencer targeting HBV cccDNA for functional cure,https://www.chromamedicine.com
FSHD_EpiEditor,Epicrispr,DUX4,FSHD,AAV,CRISPR_dCas9,eraser,"[""KRAB""]",,preclinical,CRISPRi-based epigenetic silencing of DUX4 for facioscapulohumeral dystrophy,https://www.epicrispr.com
VERVE-101,Verve Therapeutics,PCSK9,Hypercholesterolemia,LNP_mRNA,base_editor,eraser,"[""ABE""]",1,clinical,Base editing (not pure epigenetic) for permanent PCSK9 knockout - included for comparison,https://www.vervetx.com
MYC_ZF_Editor,Academic,MYC,Cancer,AAV,ZF,combo,"[""DNMT3A"",""KRAB""]",,preclinical,Zinc finger-mediated MYC silencing for broad oncology applications,
TTR_EpiEditor,Intellia (concept),TTR,ATTR Amyloidosis,LNP_mRNA,CRISPR_dCas9,combo,"[""DNMT3A"",""DNMT3L""]",,preclinical,Conceptual epigenetic approach to TTR silencing (alternative to gene editing),
